Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
- Conditions
- Smoking CessationTobacco Use Cessation
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2012-02-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 630
- Registration Number
- NCT00387946
- Locations
- 🇨🇦
Administrative Office, Laval, Quebec, Canada
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer
- Conditions
- Advanced Breast CancerBreast CancerMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2006-10-13
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 6
- Registration Number
- NCT00387907
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Malvern, Pennsylvania, United States
Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)
- Conditions
- Obesity
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2009-04-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1507
- Registration Number
- NCT00386061
- Locations
- 🇸🇪
Sanofi-Aventis, Bromma, Sweden
XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer
- Conditions
- Breast Neoplasms
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2011-04-12
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 51
- Registration Number
- NCT00386685
- Locations
- 🇨🇭
Sanofi-Aventis Administrative Office, Geneva, Switzerland
Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2010-02-24
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1110
- Registration Number
- NCT00386191
- Locations
- 🇯🇵
Sanofi-Aventis Administrative Office, Tokyo, Japan
Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions
- Conditions
- Malaria
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2008-12-09
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 22
- Registration Number
- NCT00386503
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2006-10-09
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 680
- Registration Number
- NCT00385307
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Study of Valproate in Young Patients Suffering From Epilepsy
- First Posted Date
- 2006-10-09
- Last Posted Date
- 2009-10-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 81
- Registration Number
- NCT00385411
- Locations
- 🇫🇷
Sanofi-Aventis Administrative Office, Paris, France
Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 352
- Registration Number
- NCT00384215
- Locations
- 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States
Insulin Glargine "All to Target" Trial
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2006-10-04
- Last Posted Date
- 2011-05-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 588
- Registration Number
- NCT00384085
- Locations
- 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States